ment on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 2017; 31:1792–9. 7 Fujita H, Terui T, Hayama K et al. Japanese guidelines for the management and treatment of… Click to show full abstract
ment on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 2017; 31:1792–9. 7 Fujita H, Terui T, Hayama K et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol 2018; 45:1235–70. 8 Marrakchi S, Guiggue P, Renshaw BR et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011; 365:620–8. 9 Bachelez H, Choon SE, Marrakchi S et al. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med 2021; 385:2431–40. 10 Hussain S, Berki DM, Choon SE et al. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis. J Allergy Clin Immunol 2015; 135:1067–70.
               
Click one of the above tabs to view related content.